ResearcherXiamen UniversityNo recent work listed
Li Wang
Matched on ORCID iD 0009-0005-5697-4183; OpenAlex author ID A5100336281. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 3
- N2E4, a Monoclonal Antibody Targeting Neuropilin-2, Inhibits Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma via Suppressing FAK/Erk/HIF-1α Sig… Co-author DOI 10.3389/fonc.2021.657008↗
- AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway. Co-author DOI 10.3892/or.2020.7523↗
- Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells. Co-author DOI 10.3892/ol.2018.8219↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianghua Yan · 1 shared paper, 2021 · strength 0.13
- Huanwen Wu · 1 shared paper, 2020 · strength 0.13
- Lili Wang · 1 shared paper, 2020 · strength 0.13
- Zhiwen Zhang · 1 shared paper, 2020 · strength 0.13
- Junliang Lu · 1 shared paper, 2020 · strength 0.13
- Zhiyong Liang · 1 shared paper, 2020 · strength 0.13
- Tao Shan · 1 shared paper, 2018 · strength 0.07
- Wei Li · 1 shared paper, 2018 · strength 0.07
- Shuo Chen · 1 shared paper, 2018 · strength 0.07
- Ya’an Kang · 1 shared paper, 2018 · strength 0.07
- Wenbin Yang · 1 shared paper, 2018 · strength 0.07
- Gang Cao · 1 shared paper, 2018 · strength 0.07
- Xi Chen · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.